Suchergebnisse - "Buti, Maria"

PubPharm (123)

1

Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab

enthalten in: Journal of hepatology | 2009

von Sanchez, M. | Buti, M. | Homs, M. | +3

CommentIn: J Hepatol. 2010 Mar;52(3):463-5. - PMID 20129689

2

Hepatitis C viral kinetics during treatment with peg IFN-alpha-2b in HIV/HCV coinfected patients as a function of baseline CD4+ T-cell counts

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2009

von Avidan, N. | Goldstein, D. | Rozenberg, L. | +7

3

Some oral antivirals are more cost-effective than others for the treatment of chronic hepatitis B

enthalten in: Journal of hepatology | 2009

von Casado, M. | Brosa, M. | Buti, M.

4

Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab

enthalten in: Journal of hepatology | 2009

von Sanchez, M. | Buti, M. | Homs, M. | +3

5

Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss : results of a long-term follow-up study in chronic hepatitis B patients

enthalten in: The American journal of gastroenterology | 2009

von Buster, E. | Flink, H. | Simsek, H. | +9

6

Current trends in chronic hepatitis B management : results of a questionnaire

enthalten in: European journal of gastroenterology & hepatology | 2009

von Les, I. | García-Martínez, R. | Córdoba, J. | +3

7

Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2009

von Buti, M. | Brosa, M. | Casado, M. | +2

CommentIn: J Hepatol. 2009 Oct;51(4):623-5. - PMID 19695728

8

Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2009

von Buti, M. | Brosa, M. | Casado, M. | +2

9

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

enthalten in: Journal of hepatology | 2009

von Zeuzem, S. | Gane, E. | Liaw, Y. | +13

CommentIn: J Hepatol. 2009 Jul;51(1):1-3. - PMID 19443071

10

Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B

enthalten in: Journal of hepatology | 2009

von Zeuzem, S. | Gane, E. | Liaw, Y. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]